White Papers

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers 204 115 Shields Health Solutions

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers

This white paper discusses how a specialty pharmacy acceleration company allows drug manufacturers to access the expertise of health systems and their specialty pharmacies through a single point of contact.…

Addressing Total Cost of Care Across the Specialty Population 204 115 Shields Health Solutions

Addressing Total Cost of Care Across the Specialty Population

This white paper describes the impact of health system specialty pharmacy utilizing an integrated care model on clinical outcomes and total cost of care.  

How Specialty Pharmacy Can Drive Better Outcomes in Diabetes 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Diabetes

This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and…

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis

This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…

How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis 204 115 Shields Health Solutions

How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis

This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited…

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients 204 115 Shields Health Solutions

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients

Drug manufacturers, payers and high-performing health system specialty pharmacies can leverage the size, scope and scale of a partner like Excelera to create efficiencies and improve the care of complex patients. Among the topics in this white paper:
Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environment 204 115 Shields Health Solutions

Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environment

This white paper describes the growth of health system specialty pharmacy in recent years, acknowledges the disruption caused by COVID-19, and discusses opportunities to optimize specialty pharmacy with data-driven solutions,…

How health system specialty pharmacies will help payers succeed in a value-based, data-driven future 204 115 Shields Health Solutions

How health system specialty pharmacies will help payers succeed in a value-based, data-driven future

This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…

How Specialty Pharmacy Networks are Redefining the Role of IDNs for Drug Manufacturers 204 115 Shields Health Solutions

How Specialty Pharmacy Networks are Redefining the Role of IDNs for Drug Manufacturers

This white paper points out that while complex patients usually receive care in a health system context, health systems often do not have access to specialty drugs those patients need. A network like Excelera connects drug manufacturers with health systems. • Drug access is an issue for health system specialty pharmacies. • Networks such as Excelera offer a high-quality, patient-centered specialty pharmacy solution. • Robust, real-world data from Excelera Network members, aggregated into one data feed, is one advantage.
Integrated Health Systems Can Leverage Their Strengths to Offer an Alternative to Traditional Pharmacy Benefit Management 204 115 Shields Health Solutions

Integrated Health Systems Can Leverage Their Strengths to Offer an Alternative to Traditional Pharmacy Benefit Management

This white paper provides a brief history of PBMs, describes what’s broken in the PBM industry, notes that the strengths of health systems support a realigned PBM model, and advises partnering with an outside resource when launching an integrated PBM. • The PBM industry has consolidated into a handful of misaligned and dominant players. • Consolidation has reduced competition and driven up prices. • Health systems can leverage their unique strengths to create a better PBM model.